← Back to Search

Asthma Management Interventions for Asthma

N/A
Waitlist Available
Led By Deborah A Ellis, Ph.D
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child seen in the CHM emergency department for treatment of asthma exacerbation
Child has experienced 2 or more ED visits and/or inpatient admissions in prior 12 months (i.e. poorly controlled asthma)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 6 months, change from baseline at 12 months and change from baseline at 18 months
Awards & highlights

Study Summary

This trial will compare two asthma interventions to see which one is more effective in reducing symptoms, improving management, and lung function, and decreasing emergency visits and hospitalizations.

Who is the study for?
This trial is for children aged 12-16 with moderate to severe asthma, who've been to the emergency department at CHM for an asthma attack. They must have had at least two hospital visits in the past year and live within 20 miles of CHM. The child's parent or guardian must agree to participate, and they can't join if there are severe mental health issues, cognitive impairments, or current suicidal/homicidal tendencies.Check my eligibility
What is being tested?
The study compares 'Reach for Control' (RFC) with 'Michigan MATCH' in improving asthma symptoms and management while reducing emergency visits. It integrates these interventions into hospital EDs via community health workers and tests their real-world effectiveness.See study design
What are the potential side effects?
While specific side effects aren't detailed here, typical concerns may include discomfort from intervention procedures or stress related to participation. Side effects will depend on the nature of each intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child was treated for an asthma attack in the CHM emergency department.
Select...
My child has been to the ER or admitted to the hospital 2+ times in the last year for asthma.
Select...
My child is between 12 and 16 years old and has moderate to severe asthma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 6 months, 12 months, and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 6 months, 12 months, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Emergency Department Visits
Secondary outcome measures
Asthma Symptom Frequency
Family Asthma Management System Scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Reach for ControlExperimental Treatment1 Intervention
Reach For Control is a multi-component, home-based family therapy that targets the multiple causes of poor adolescent asthma management across individual, family and community systems.
Group II: Michigan MATCHActive Control1 Intervention
Program endorsed by the State of Michigan for treatment of poorly controlled asthma.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reach for Control
2018
N/A
~80

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor
307 Previous Clinical Trials
108,398 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,835 Previous Clinical Trials
47,310,567 Total Patients Enrolled
6 Trials studying Childhood Asthma
2,086 Patients Enrolled for Childhood Asthma
Deborah A Ellis, Ph.DPrincipal InvestigatorWayne State University
1 Previous Clinical Trials
49 Total Patients Enrolled

Media Library

MATCH Clinical Trial Eligibility Overview. Trial Name: NCT03317977 — N/A
Childhood Asthma Research Study Groups: Reach for Control, Michigan MATCH
Childhood Asthma Clinical Trial 2023: MATCH Highlights & Side Effects. Trial Name: NCT03317977 — N/A
MATCH 2023 Treatment Timeline for Medical Study. Trial Name: NCT03317977 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this clinical trial still underway?

"According to clinicaltrials.gov, this specific research program is no longer signing up participants. It was initially listed on February 1st 2018 and its most recent update occurred on May 2nd 2022. Nevertheless, there are 327 other trials that are still accepting applicants presently."

Answered by AI

What criteria does one need to meet in order to qualify for participation in this research?

"This clinical trial seeks to enrol 170 children aged 12-16 who have experienced two or more emergency department visits and/or hospital admissions due to their asthma in the past year. To be eligible, these minors must present with moderate-to-severe persistent asthma, should reside within 20 miles of CHM (for home data collection), and need a parent/legal guardian's permission for participation in family treatment."

Answered by AI

Is this research endeavor enrolling elderly individuals?

"As per the study's inclusion criteria, adolescents aged 12 to 16 are eligible for participation."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Translating an Efficacious Illness Management Intervention for Youth With Asthma
Deborah Ellis, Ph.D. 2018. "Translating an Efficacious Illness Management Intervention for Youth With Asthma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03317977.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top